$86.47
+0.51 (+0.59%)
Last updated: May 30, 2026 23:24
Fundamentals Overview
Edwards Lifesciences Corporation is near the high of its 52-week range with premium valuation, trading relatively flat today.
Valuation premium
Intrinsic value (DCF)
-26.4% downside vs price
Profitability
Risk (Beta)
0.87 — in line vol
Earnings & growth
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
Analyst grade: B+ · Sentiment improving (2 upgrades) · 3M vs Healthcare sector: +10.3%
Pressures (Sell):
DCF 26.4% downside vs price · 3M vs S&P 500: -5.1%
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: B+. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 9, Hold: 5, Neutral: 4, Outperform: 4, Overweight: 8.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $63.64; current price is $86.47. That’s a -26.4% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 45.95 |
| DCF value (model) | $63.64 (-26.4% vs price) |
| PEG (TTM) | N/A |
| P/B (TTM) | 4.85 |
| P/S (TTM) | 7.9 |
| P/FCF (TTM) | 45.7 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 4.42 |
| Quick Ratio (TTM) | 3.63 |
| Cash Ratio (TTM) | 1.74 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 17.34% |
| Gross margin (TTM) | 78.01% |
| Operating margin (TTM) | 27.62% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for EW.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| Barclays | maintain | Overweight | Overweight | 2026-04-27 |
| Evercore ISI Group | maintain | Outperform | Outperform | 2026-04-24 |
| Truist Securities | maintain | Hold | Hold | 2026-04-24 |
| BTIG | maintain | Buy | Buy | 2026-04-24 |
| Canaccord Genuity | maintain | Hold | Hold | 2026-04-24 |
| Baird | maintain | Neutral | Neutral | 2026-04-24 |
| Mizuho | maintain | Outperform | Outperform | 2026-04-13 |
| Evercore ISI Group | maintain | Outperform | Outperform | 2026-04-06 |
| Truist Securities | maintain | Hold | Hold | 2026-02-11 |
| Wells Fargo | maintain | Overweight | Overweight | 2026-02-11 |
| Goldman Sachs | maintain | Buy | Buy | 2026-02-11 |
| Piper Sandler | maintain | Overweight | Overweight | 2026-02-11 |
| BTIG | maintain | Buy | Buy | 2026-02-11 |
| Stifel | maintain | Buy | Buy | 2026-01-20 |
| Piper Sandler | maintain | Overweight | Overweight | 2026-01-20 |
| Barclays | maintain | Overweight | Overweight | 2026-01-12 |
| UBS | maintain | Neutral | Neutral | 2026-01-12 |
| TD Cowen | upgrade | Hold | Buy | 2026-01-09 |
| Stifel | maintain | Buy | Buy | 2026-01-07 |
| JP Morgan | upgrade | Neutral | Overweight | 2025-12-18 |
| Canaccord Genuity | maintain | Hold | Hold | 2025-12-17 |
| Baird | maintain | Neutral | Neutral | 2025-12-16 |
| Citigroup | maintain | Buy | Buy | 2025-12-11 |
| Barclays | maintain | Overweight | Overweight | 2025-12-08 |
| Canaccord Genuity | maintain | Hold | Hold | 2025-12-05 |
| BTIG | maintain | Buy | Buy | 2025-12-05 |
| RBC Capital | maintain | Outperform | Outperform | 2025-12-05 |
| Wells Fargo | maintain | Overweight | Overweight | 2025-12-05 |
| Stifel | maintain | Buy | Buy | 2025-12-05 |
| Baird | maintain | Neutral | Neutral | 2025-12-05 |